|
Weeks
|
WBC
|
Lymphocytes
|
CD3+ cells
|
B lymphocyte
|
|---|
| |
a.n. x 109/L
|
%
|
a.n. x 109/L
|
%
|
a.n. x 109/L
|
%
|
a.n. x 109/L
|
|---|
| |
Non-smokers (placebo, n = 27)
|
|---|
|
0
|
7.62 ± 1.89
|
41.96 ± 9.34
|
3.12 ± 0.77
|
63.54 ± 7.03
|
1.99 ± 0.60
|
10.19 ± 4.06
|
0.35 ± 0.26
|
|
12
|
7.29 ± 2.10
|
42.39 ± 6.12
|
3.04 ± 0.84
|
65.96 ± 6.70
|
2.00 ± 0.56
|
10.89 ± 3.56
|
0.33 ± 0.14
|
|
24
|
7.14 ± 1.53
|
41.85 ± 8.85
|
2.94 ± 0.72
|
64.27 ± 7.12
|
1.88 ± 0.50
|
11.00 ± 3.88
|
0.32 ± 0.12
|
| |
Non-smokers (palmvitee, n = 29)
|
|
0
|
8.32 ± 1.55
|
40.52 ± 6.17
|
3.36 ± 0.70
|
62.07 ± 8.02
|
2.09 ± 0.52
|
11.97 ± 4.00
|
0.40 ± 0.13+
|
|
12
|
8.27 ± 2.08
|
40.39 ± 6.09
|
3.33 ± 0.74
|
62.72 ± 7.60
|
2.10 ± 0.55
|
12.45 ± 4.67
|
0.41 ± 0.16+
|
|
24
|
8.02 ± 1.50
|
38.05 ± 5.80+
|
3.05 ± 0.77
|
61.66 ± 14.23
|
1.96 ± 0.55
|
13.72 ± 4.53+
|
0.41 ± 0.15+
|
| |
Smokers (placebo, n = 28)
|
|
0
|
9.74 ± 2.31
|
40.44 ± 7.39
|
3.91 ± 1.14
|
63.50 ± 7.87
|
2.47 ± 0.71
|
15.54 ± 5.06
|
0.64 ± 0.38
|
|
12
|
9.38 ± 2.45
|
40.53 ± 8.20
|
3.76 ± 1.16
|
63.82 ± 8.34
|
2.40 ± 0.65
|
16.14 ± 4.70
|
0.59 ± 0.33
|
|
24
|
8.81 ± 2.30
|
38.00 ± 8.68
|
3.30 ± 1.04
|
66.11 ± 10.78
|
2.14 ± 0.63
|
15.25 ± 4.40
|
0.52 ± 0.29
|
| |
Smokers (palmvitee, n = 30)
|
|
0
|
8.43 ± 1.86
|
39.27 ± 6.20
|
3.27 ± 0.75
|
65.77 ± 7.75
|
2.16 ± 0.69
|
14.06 ± 3.81
|
0.45 ± 0.15
|
|
12
|
8.13 ± 2.29
|
40.07 ± 7.04
|
3.19 ± 0.72
|
66.27 ± 6.59
|
2.13 ± 0.58
|
14.30 ± 4.09
|
0.45 ± 0.16
|
|
24
|
8.06 ± 2.10
|
37.68 ± 7.29
|
3.01 ± 0.88
|
66.83 ± 7.28
|
2.02 ± 0.69
|
14.40 ± 4.03
|
0.43 ± 0.16
|
- Results are shown as mean ± SD. + indicates significant difference as compared to non-smokers taking placebo (p < 0.05), a.n. represents actual number.
